| Aspen Pharma Schweiz GmbH - Cabometyx 20 mg, Filmtabletten | | 66471 | | 01 | | Cabometyx 20 mg | | Filmtabletten | | L01EX07 | | Cabozantinib | | 15.12.2017 | | |
| | Composition | | cabozantinibum 20 mg ut cabozantinibi l-malas 25.34 mg, cellulosum microcristallinum, lactosum 15.54 mg, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.9 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, triacetinum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Cabozantinibum | 20 mg |
| | BAG: Active Agent | Dose |
|---|
| Cabozantinibum | 20 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactosum | 15.54 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 4670.20 | 5095.55 | A | SL | No |
|
|
